Caxton Associates (New York)’s Adaptive Biotechnologies ADPT Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q4	$739K	Buy	+123,287	New	+$739K	0.02%	263
2022 Q2	–	Sell	-30,690	Closed	-$426K	–	530
2022 Q1	$426K	Buy	+30,690	New	+$426K	0.03%	262